Gevokizumab Completed Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01066715Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
NCT01144975Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus